Switch to:
More From Other Websites
Esperion drug succeeds in lowering LDL cholesterol -study Oct 01 2014
Portola Pharmaceuticals Announces Phase 3 ANNEXA(TM)-A Study of Andexanet Alfa and Eliquis... Oct 01 2014
European Buyers Cross Atlantic in $87 Billion U.S. Deal Spree Sep 30 2014
Viagra ads target women for 1st time Sep 30 2014
[video] Viagra's New Ad Campaign to Target Women for First Time Sep 30 2014
1:16 am Pfizer and Kyowa Hakko Kirin to collaborate on immuno-oncology combination study Sep 30 2014
Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study Sep 29 2014
Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study Sep 29 2014
Business events scheduled for Tuesday Sep 29 2014
Business events scheduled for Tuesday Sep 29 2014
Pfizer Inc. Stock Fails To Break Out: Is It Headed Back Down? Sep 29 2014
Why multinationals aren't adding U.S. jobs Sep 28 2014
Pfizer drug effective in patients with rare lung cancer -study Sep 27 2014
Pfizer’s Lung Cancer Drug Helps Patients With Gene Defect Sep 27 2014
[video] Stock Pops & Drops: AGIO, MO, PFE & MU Sep 26 2014
Pfizer Acquires InnoPharma, Injectables Business to Benefit Sep 26 2014
Focusing Solely On Animal Health Sets Zoetis Apart Sep 26 2014
GlycoMimetics Announces a Delay in the Initiation of the Phase 3 Trial With Rivipansel Sep 26 2014
Pain Therapeutics Expands Pipeline With FENROCK(TM), an Abuse-Deterrent Pain Patch Sep 26 2014
[video] Fast Money Final Trade: PFE, DOW, VRTX & the dollar Sep 25 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

SEENSCO
ReplySEENSCO - 3 months ago
PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK